Commentary
Agriculture
Is California Now At War With Farms?
California leads the nation in agricultural production. It’s no exaggeration to say this state feeds the world out of its fertile Central Valley. But that rich land has become a battlefield. California is the nation’s No. 1 state in agriculture commodity sales, with its share nearly double that of no. 2 Iowa. ...
Commentary
Facts, Economic Reason No Match for Left’s Drug Pricing Fixation
Last week, the U.S. Senate Finance Committee held a hearing, “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” It’s rare to see so many falsehoods in so few words. The idea that drug-price inflation is especially bad or that it poses some sort of threat to ...
CEQA
UC Berkeley Case Shows Why Comprehensive Reform Badly Needed to End CEQA Abuse
By Chris Carr The California Supreme Court last week declined to stay a lower court order in a case involving a housing and classroom complex under construction on the UC Berkeley campus. This will effectively shut the door to one of America’s finest public universities for thousands of prospective students. ...
Commentary
Government red tape would strangle patient access to medication
Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration’s “accelerated approval” pathway — the program responsible for bringing promising medicines to patients years ahead of schedule. The accelerated approval pathway is a rare example of government working efficiently. ...
Climate Change
States and Municipal Lawsuits Undermine Innovative Climate Solutions
Cities and states are attempting to set the nation’s energy policies through the judicial system rather than the appropriate legislative process. Dozens of states and localities including New York City, Baltimore, and various California cities have filed suits claiming that oil and gas companies should be held responsible for the ...
Commentary
Diversity Smokescreen
By Henry I. Miller, M.S., M.D. and Andrew I. Fillat The Supreme Court has agreed to hear two more cases challenging the use of race as a criterion in college admissions, as has allegedly happened at Harvard University (a private institution) and the University of North Carolina (public). On the ...
Commentary
Biden’s ‘Test to Treat’ COVID Plan: Good Sound Bite, Bad Policy
It ignores the risk of hazardous drug-drug interactions with the Pfizer pill. As someone who has closely followed and written extensively about the development of COVID-19 vaccines and drug treatments since the beginning of the pandemic, one pronouncement in President Joe Biden’s State of the Union speech raised red flags: “We’re also ready with ...
Commentary
The private sector can help solve our doctor shortage
The pandemic has laid bare a crisis we’ve ignored for far too long — our chronic doctor shortage. According to the Association of American Medical Colleges, the United States faces a shortfall of up to 124,000 physicians over the next decade. This is a supply problem, as the demand for ...
Commentary
Drug Pricing Reforms Should Expand Choice, Not Government Control
As President Biden‘s recent State of the Union address made clear, drug pricing will remain a top policy issue for the foreseeable future. The president is correct that something must be done, but his proposals are wrongheaded and will only make things worse. Instead of focusing on government price controls, Congress ...
Commentary
States are eyeing a public option through rose-colored glasses
The Affordable Care Act will notch its 12th birthday later this month. To get the measure through Congress and to President Obama’s desk for his signature, Democrats had to cut one of progressives’ signature proposals—a public health insurance option. But the public option didn’t die all those years ago. President ...
Is California Now At War With Farms?
California leads the nation in agricultural production. It’s no exaggeration to say this state feeds the world out of its fertile Central Valley. But that rich land has become a battlefield. California is the nation’s No. 1 state in agriculture commodity sales, with its share nearly double that of no. 2 Iowa. ...
Facts, Economic Reason No Match for Left’s Drug Pricing Fixation
Last week, the U.S. Senate Finance Committee held a hearing, “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” It’s rare to see so many falsehoods in so few words. The idea that drug-price inflation is especially bad or that it poses some sort of threat to ...
UC Berkeley Case Shows Why Comprehensive Reform Badly Needed to End CEQA Abuse
By Chris Carr The California Supreme Court last week declined to stay a lower court order in a case involving a housing and classroom complex under construction on the UC Berkeley campus. This will effectively shut the door to one of America’s finest public universities for thousands of prospective students. ...
Government red tape would strangle patient access to medication
Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration’s “accelerated approval” pathway — the program responsible for bringing promising medicines to patients years ahead of schedule. The accelerated approval pathway is a rare example of government working efficiently. ...
States and Municipal Lawsuits Undermine Innovative Climate Solutions
Cities and states are attempting to set the nation’s energy policies through the judicial system rather than the appropriate legislative process. Dozens of states and localities including New York City, Baltimore, and various California cities have filed suits claiming that oil and gas companies should be held responsible for the ...
Diversity Smokescreen
By Henry I. Miller, M.S., M.D. and Andrew I. Fillat The Supreme Court has agreed to hear two more cases challenging the use of race as a criterion in college admissions, as has allegedly happened at Harvard University (a private institution) and the University of North Carolina (public). On the ...
Biden’s ‘Test to Treat’ COVID Plan: Good Sound Bite, Bad Policy
It ignores the risk of hazardous drug-drug interactions with the Pfizer pill. As someone who has closely followed and written extensively about the development of COVID-19 vaccines and drug treatments since the beginning of the pandemic, one pronouncement in President Joe Biden’s State of the Union speech raised red flags: “We’re also ready with ...
The private sector can help solve our doctor shortage
The pandemic has laid bare a crisis we’ve ignored for far too long — our chronic doctor shortage. According to the Association of American Medical Colleges, the United States faces a shortfall of up to 124,000 physicians over the next decade. This is a supply problem, as the demand for ...
Drug Pricing Reforms Should Expand Choice, Not Government Control
As President Biden‘s recent State of the Union address made clear, drug pricing will remain a top policy issue for the foreseeable future. The president is correct that something must be done, but his proposals are wrongheaded and will only make things worse. Instead of focusing on government price controls, Congress ...
States are eyeing a public option through rose-colored glasses
The Affordable Care Act will notch its 12th birthday later this month. To get the measure through Congress and to President Obama’s desk for his signature, Democrats had to cut one of progressives’ signature proposals—a public health insurance option. But the public option didn’t die all those years ago. President ...
